Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 23, Issue 5, Pages 1156-1164
Publisher
Oxford University Press (OUP)
Online
2011-09-10
DOI
10.1093/annonc/mdr361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARP expression in early breast cancer and its predictive value for response to neoadjuvant chemotherapy.
- (2017) S. Loibl et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy
- (2011) Pawel Domagala et al. BREAST CANCER RESEARCH AND TREATMENT
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis
- (2010) Anthony Gonçalves et al. BREAST CANCER RESEARCH AND TREATMENT
- A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
- (2010) M. Graeser et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Making the best of PARP inhibitors in ovarian cancer
- (2010) Susana Banerjee et al. Nature Reviews Clinical Oncology
- Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin
- (2009) F. Rojo et al. CLINICAL CANCER RESEARCH
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poly(ADP-Ribose) Polymerase Inhibition Down-Regulates Expression of Metastasis-Related Genes in CT26 Colon Carcinoma Cells
- (2009) Ming Li et al. PATHOBIOLOGY
- RETRACTED ARTICLE: Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Expression in Cutaneous Malignant Melanomas as a New Molecular Marker of Aggressive Tumor
- (2009) Béla Csete et al. PATHOLOGY & ONCOLOGY RESEARCH
- Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity
- (2008) Lucio Tentori et al. EUROPEAN JOURNAL OF CANCER
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
- (2008) Daniele Generali et al. JOURNAL OF CLINICAL ONCOLOGY
- Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1-Dependent Gene Expression
- (2008) M. Elser et al. MOLECULAR CANCER RESEARCH
- The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases
- (2007) Paul et al. Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More